Lyssia Belarif - Publications

First-in-Human Study in Healthy Subjects with the Noncytotoxic Monoclonal Antibody OSE-127, a Strict Antagonist of IL-7Rα.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: August 25, 2022

SIRPγ-CD47 Interaction Positively Regulates the Activation of Human T Cells in Situation of Chronic Stimulation.

Journal: Frontiers in immunology

Published: June 29, 2021

Agonist anti-ChemR23 mAb reduces tissue neutrophil accumulation and triggers chronic inflammation resolution.

Journal: Science advances

Published: June 03, 2020

Full antagonist of the IL-7 receptor suppresses chronic inflammation in non-human primate models by controlling antigen-specific memory T cells.

Journal: Cell stress

Published: June 22, 2019

Interleukin-7 receptor blockade by an anti-CD127 monoclonal antibody in nonhuman primate kidney transplantation.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: March 12, 2019

IL-7 receptor influences anti-TNF responsiveness and T cell gut homing in inflammatory bowel disease.

Journal: The Journal of clinical investigation

Published: April 16, 2018

IL-7 receptor blockade blunts antigen-specific memory T cell responses and chronic inflammation in primates.

Journal: Nature communications

Published: December 06, 2017

Selective CD28 antagonist prevents Aldara-induced skin inflammation in non-human primates.

Journal: Experimental dermatology

Published: October 19, 2015

Selective CD28 Antagonist Blunts Memory Immune Responses and Promotes Long-Term Control of Skin Inflammation in Nonhuman Primates.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: August 11, 2015

Advantages of Papio anubis for preclinical testing of immunotoxicity of candidate therapeutic antagonist antibodies targeting CD28.

Journal: mAbs

Published: March 07, 2014